LABS.TO

MediPharm Labs Corp. [LABS.TO] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

LABS.TO Stock Summary

Top 10 Correlated Stocks

LABS.TO


In the News

LABS.TO Financial details

Company Rating
Neutral
Market Cap
34.11M
Income
-15.73M
Revenue
29.55M
Book val./share
0.13
Cash/share
0.03
Dividend
-
Dividend %
-
Employees
130
Optionable
No
Shortable
Yes
Earnings
27 Mar 2024
P/E
-2.06
Forward P/E
8
PEG
0.26
P/S
0.95
P/B
0.59
P/C
2.67
P/FCF
-1.92
Quick Ratio
2.11
Current Ratio
3.27
Debt / Equity
0.05
LT Debt / Equity
0
-
-
EPS (TTM)
-0.05
EPS next Y
0.01
EPS next Q
-0.01
EPS this Y
-50%
EPS next Y
-125.1%
EPS next 5Y
-876.36%
EPS last 5Y
-1.73%
Revenue last 5Y
16.75%
Revenue Q/Q
-11.25%
EPS Q/Q
44.93%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-23%
ROE
-28%
ROC
-0.35%
Gross Margin
13%
Oper. Margin
-66%
Profit Margin
-53%
Payout
-
Shs Outstand
401.28M
Shs Float
384.5M
-
-
-
-
Target Price
-
52W Range
0.055-0.1
52W High
-
52W Low
-
RSI
57
Rel Volume
2.17
Avg Volume
174.58K
Volume
378.75K
Perf Week
23.08%
Perf Month
14.29%
Perf Quarter
6.67%
Perf Half Y
0%
-
-
-
-
Beta
1.045
-
-
Volatility
0.01%, 0.01%
Prev Close
-11.11%
Price
0.08
Change
-15.79%

LABS.TO Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.150.960.260.090.08
Net income per share
-0.120.01-0.48-0.22-0.11
Operating cash flow per share
-0.16-0.19-0.27-0.05-0.06
Free cash flow per share
-0.37-0.43-0.33-0.06-0.06
Cash per share
0.120.290.160.140.09
Book value per share
0.40.980.570.330.2
Tangible book value per share
0.40.970.560.330.2
Share holders equity per share
0.40.980.570.330.2
Interest debt per share
0.090.080.190.040
Market cap
221.53M519.67M73.43M46.23M19.38M
Enterprise value
219.68M491.62M71.98M12.34M-4.13M
P/E ratio
-26.34459.48-1.09-0.84-0.65
Price to sales ratio
21.724.022.042.130.88
POCF ratio
-19.93-20.57-1.94-3.5-1.21
PFCF ratio
-8.62-9.01-1.62-3.3-1.14
P/B Ratio
8.013.950.940.560.35
PTB ratio
8.013.950.940.560.35
EV to sales
21.543.820.57-0.19
Enterprise value over EBITDA
-30.9649.38-1.2-0.330.16
EV to operating cash flow
-19.77-19.46-1.91-0.930.26
EV to free cash flow
-8.55-8.52-1.59-0.880.24
Earnings yield
-0.040-0.91-1.19-1.55
Free cash flow yield
-0.12-0.11-0.62-0.3-0.87
Debt to equity
0.220.080.2400.01
Debt to assets
0.140.060.1600.01
Net debt to EBITDA
0.26-2.820.020.910.92
Current ratio
1.794.153.367.385.01
Interest coverage
-22.0510.32-9.22-4.66-952.68
Income quality
1.31-22.340.560.240.54
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.540.240.680.850.83
Research and developement to revenue
0.030.010.060.060.05
Intangibles to total assets
00000
Capex to operating cash flow
1.311.280.20.060.05
Capex to revenue
-1.43-0.25-0.21-0.04-0.04
Capex to depreciation
-14.84-12.82-0.69-0.14-0.3
Stock based compensation to revenue
0.190.120.070.110.13
Graham number
1.040.432.481.280.7
ROIC
-0.240.01-0.69-0.59-0.52
Return on tangible assets
-0.20.01-0.57-0.59-0.46
Graham Net
0.040.360.140.180.11
Working capital
11.73M90.86M57.28M56.67M37.89M
Tangible asset value
27.84M131.23M78.19M83.1M55.97M
Net current asset value
11.73M82.1M41.7M56.33M37.86M
Invested capital
0.220.080.2400.01
Average receivables
3.21M16.98M31.21M26.11M15.25M
Average payables
4M13.52M12.3M4.27M3.27M
Average inventory
4.7M30.45M36.81M16.56M9.38M
Days sales outstanding
230.0377.77353.49291.7217.03
Days payables outstanding
468.1680.5625.3229.5453.75
Days of inventory on hand
550.87217.66101.02108.4118.11
Receivables turnover
1.594.691.031.251.68
Payables turnover
0.784.5314.4212.366.79
Inventory turnover
0.661.683.613.373.09
ROE
-0.30.01-0.86-0.66-0.54
Capex per share
-0.21-0.24-0.0500

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.030.020.020.020.02
Net income per share
-0.03-0.02-0.01-0.01-0.01
Operating cash flow per share
-0.010-0.01-0.02-0.01
Free cash flow per share
-0.010-0.01-0.02-0.01
Cash per share
0.070.090.070.040.03
Book value per share
0.230.20.190.150.13
Tangible book value per share
0.230.20.190.150.13
Share holders equity per share
0.230.20.190.150.13
Interest debt per share
0000.010.01
Market cap
18.5M19.38M19.75M21.46M32.45M
Enterprise value
218.33K-4.13M-180.46K9.63M22.22M
P/E ratio
-0.59-0.86-1.6-1.98-1.88
Price to sales ratio
2.553.453.382.243.82
POCF ratio
-6.41-115.36-6.47-2.85-10.04
PFCF ratio
-5.78-40.63-6.42-2.82-9.29
P/B Ratio
0.310.350.370.360.59
PTB ratio
0.310.350.370.360.59
EV to sales
0.03-0.74-0.0312.61
Enterprise value over EBITDA
-0.031.210.07-1.43-6.24
EV to operating cash flow
-0.0824.60.06-1.28-6.88
EV to free cash flow
-0.078.660.06-1.27-6.36
Earnings yield
-0.42-0.29-0.16-0.13-0.13
Free cash flow yield
-0.17-0.02-0.16-0.35-0.11
Debt to equity
0.020.0100.050.05
Debt to assets
0.020.0100.040.04
Net debt to EBITDA
2.556.887.691.752.87
Current ratio
4.875.015.33.683.27
Interest coverage
-502.88-417.2-666.6-69.35-29.23
Income quality
0.360.030.992.790.75
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.510.680.390.670.55
Research and developement to revenue
0.030.030.010.010.01
Intangibles to total assets
0000.010.02
Capex to operating cash flow
0.111.840.010.010.08
Capex to revenue
-0.04-0.060-0.01-0.03
Capex to depreciation
-0.42-0.57-0.05-0.1-0.42
Stock based compensation to revenue
0.020.250.130.060.05
Graham number
0.390.30.220.150.17
ROIC
-0.13-0.07-0.07-0.13-0.07
Return on tangible assets
-0.11-0.09-0.05-0.04-0.06
Graham Net
0.090.110.090.050.04
Working capital
41.48M37.89M36M34.02M28.95M
Tangible asset value
60.44M55.97M53.63M58.13M54.13M
Net current asset value
41.43M37.86M35.98M32.19M28.87M
Invested capital
0.020.0100.050.05
Average receivables
14.26M13.44M13.46M14.59M14.67M
Average payables
3.61M3.62M2.96M3.06M3.07M
Average inventory
11.43M8.54M7.95M9.73M10.86M
Days sales outstanding
170.23210.75212.15144.76147.46
Days payables outstanding
39.3458.9339.4138.3835.8
Days of inventory on hand
99.03129.48134.01116.81153.7
Receivables turnover
0.530.430.420.620.61
Payables turnover
2.291.532.282.342.51
Inventory turnover
0.910.70.670.770.59
ROE
-0.13-0.1-0.06-0.05-0.08
Capex per share
00000

LABS.TO Frequently Asked Questions

What is MediPharm Labs Corp. stock symbol ?

MediPharm Labs Corp. is a CA stock , located in Barrie of On and trading under the symbol LABS.TO

What is MediPharm Labs Corp. stock quote today ?

MediPharm Labs Corp. stock price is $0.08 today.

Is MediPharm Labs Corp. stock public?

Yes, MediPharm Labs Corp. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated Stocks
Similar Market Cap